Castroviejo-Bermejo, M., Cruz Zambrano, C., Llop Guevara, A., Gutiérrez-Enríquez, S., Ducy, M., Ibrahim, Y. H., . . . Serra, V. (2018). A RAD51 assay feasible in routine tumor samples calls inhibitor response beyond BRCA mutation.
Citación estilo ChicagoCastroviejo-Bermejo, Marta|||0000-0002-8540-5837, et al. A RAD51 Assay Feasible in Routine Tumor Samples Calls Inhibitor Response Beyond BRCA Mutation. 2018.
Cita MLACastroviejo-Bermejo, Marta|||0000-0002-8540-5837, et al. A RAD51 Assay Feasible in Routine Tumor Samples Calls Inhibitor Response Beyond BRCA Mutation. 2018.
Precaución: Estas citas no son 100% exactas.